Cellectar Biosciences CLRB
NASDAQ CLRB
$2.59 +0.00 (+0.00%)
As of: Aug 21, 2026 · 3:58 PM EDT

Cellectar Biosciences (CLRB) Property, Plant & Equipment (Net) (2010 - 2026)

Cellectar Biosciences (CLRB) Property, Plant & Equipment (Net) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Cellectar Biosciences 6.73 Mn 6.73 Mn - 304,173.00

Historic Data

Download Data
DateValue
Jun 30, 2026 304,173.00
Jun 30, 2026 304,173.00
Dec 31, 2025 549,405.00
Dec 31, 2025 549,405.00
Sep 30, 2025 595,271.00
Sep 30, 2025 595,271.00
Jun 30, 2025 647,549.00
Jun 30, 2025 647,549.00
Mar 31, 2025 700,826.00
Mar 31, 2025 700,826.00
Dec 31, 2024 757,121.00
Dec 31, 2024 757,121.00
Sep 30, 2024 910,131.00
Sep 30, 2024 910,131.00
Jun 30, 2024 978,701.00
Jun 30, 2024 978,701.00
Mar 31, 2024 1.02 Mn
Mar 31, 2024 1.02 Mn
Dec 31, 2023 1.09 Mn
Dec 31, 2023 1.09 Mn